EMS Ltd Q1 FY27 Results

EMS Ltd delivered a bruising Q4 FY26, posting ₹84 Cr standalone revenue (down ~36% YoY) as election stoppages, government permission delays, and payment system frictions crushed execution. Management flagged ₹100+ Cr of unbilled work-in-progress carried into Q1 FY27, and guided that early FY27 remains in recovery mode—with Q1 explicitly not expected to be strong. But the quarter also saw the company land three landmark sewerage and water infrastructure contracts (₹158 Cr from Delhi Jal Board LOI, ₹103 Cr+ from UP Jal Nigam projects), which dramatically reshape the medium-term order pipeline. The Street's consensus Sell reflects this tension: a ₹1,837+ Cr order book on a ₹2,130 Cr market cap suggests 0.9x book-to-cap value, but execution risk from the prior year's slippages has eroded confidence in management's ability to convert wood into wickets.

Strong Q1: Revenue delivers ₹120+ Cr (i.e., ₹100+ Cr WIP clears into Q1), margins hold at 12–14%, and management reinstates FY27 guidance above ₹1,000 Cr (vs. current heuristic based on 1/3 of order book). Would signal execution is de-risked post-elections and prior slippages are behind. Stock likely re-rates on execution credibility. Weak Q1: Revenue stays flat/weak (₹90–100 Cr), margins compress below 10%, and management further pushes out WIP billing into Q2/Q3. Would confirm the recovery narrative is slower and raise fears that the ₹100+ Cr WIP may persist through the year, pressuring cash and balance-sheet ratios. Bear case intensifies.

Management's FY27 revenue target of ₹1,000 Cr is anchored to a ~₹3,000 Cr order book and a heuristic 2–3 year execution cycle (i.e., annual revenue at ~1/3 of total book). With ₹2,100+ Cr confirmed post-July, that math holds if execution normalizes. The critical path: (1) Clear the ₹100+ Cr WIP from Q4 in Q1/Q2; (2) de-risk the 15-month timelines on the new Delhi Jal Board and UP projects; (3) maintain cost discipline as margins recover toward the 15–17% target. Management indicated PAT margin normalization will take another 2–3 quarters (into FY27), so Q2 and Q3 will be pivotal. If delays persist (elections, permissions, payment friction repeat), FY27 risks undershooting.

EMS Ltd's consolidated PAT fell 59.3% YoY to ₹15.49 Cr (from ₹38.06 Cr in Q1 FY26) as consolidated revenue dropped 34.2% YoY to ₹157.24 Cr (from ₹238.89 Cr). Standalone tells the same story: PAT down 59.8% YoY to ₹15.03 Cr on revenue down 40.5% YoY. The QoQ numbers the company's own press release headlines — consolidated PAT +171% and revenue +30.5% versus Q4 FY26 — are real, but they are a bounce off a depressed Q4 base (₹5.71 Cr PAT, ₹120.50 Cr revenue) that management itself had called disappointing; on the more meaningful year-on-year basis this is a clear decline, not the growth story the release frames it as.

The decline is concentrated in the core contracting segment: segment revenue nearly halved YoY, to ₹129.45 Cr from ₹217.19 Cr, while the smaller flex-sheet/paper manufacturing unit grew (₹27.79 Cr vs ₹21.70 Cr) but is too small to offset it. Margins compressed in step — consolidated NPM fell to ~9.9% from ~15.9% a year ago, and OPM to ~17.9% from ~22.7% — consistent with slower billing/execution on ongoing sewerage and water-infrastructure works rather than any pricing or one-off issue (none flagged, and none evident in the accounts).

The stock went into the print at ₹381.25, down 11.2% over the past month of trading.

No exceptional items in either period — accounts tie out exactly (PBT less tax equals reported PAT, standalone and consolidated)

Against the guidance on record from the company's Q3 FY26 concall (Feb 2026) — "strong growth and recovery anticipated from Q1 FY27," FY26 PAT margin above 15%, and an order book target of ₹3,000 Cr by Q1 FY27 — this print is a miss on every count: order book stood at ₹2,328.91 Cr as of 30 June 2026, and NPM is well under the 15% bar. However, it is broadly consistent with more cautious commentary management gave on the subsequent Q4 FY26 call, where it flagged that Q1 FY27 was not expected to be strong and that PAT margin normalization to 15-17% would take a further 2-3 quarters as accumulated unbilled work-in-progress clears — this quarter reads as roughly on that (lowered) track. No sell-side estimates for this small-cap name were found, so vs-street is unknown. Management's FY27 target, per that same Q4 call, is ₹1,000 Cr consolidated revenue; Q1's ₹157.24 Cr is only ~16% of that, implying a large ramp is still needed through the rest of the year.

Order book of Rs. 2,329 Cr provides multi-year visibility, but Q1's -34% YoY revenue and -59% PAT collapse belie the recovery narrative. Geographic concentration (42% UP, 61% Uttarakhand) and monsoon seasonality create structural margin drag; fixed cost base amplifies downside when execution stalls. Full-year Rs. 900-950 Cr target requires flawless Q2-Q4 execution in historically weak season.

Analysts pressed hard on margin recovery durability (Darshil Pandya) and H2 execution math (Dhruv Hingorani). Hingorani skeptical on Rs. 950 Cr target feasibility; management confident but offered no structural mitigation for monsoon/weather risk. Sanjay deflected on top-5 client concentration (gave state-level, not customer names). Overall: management held tone but credibility dented by order book miss.

Score 6/10. Clear on project timelines and order book mechanics. Defensive on margin recovery; blamed externalities (weather, elections, bureaucracy) but offered no structural solution. Evasive on top-5 client concentration (gave state-level, not customer names). Missed order book target (Rs. 3,000→2,329 Cr). Revenue -34% YoY, PAT -59% YoY. Prior FY26 margin guidance (>15% PAT) not achieved in Q4 FY26. Track record mixed; recovery narrative not yet corroborated by delivered numbers.